Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Jul-24 6:00 PM View:  | Usman Nassim Director | Targacept, Inc. (GYRE) | 28-Jun-24 | Planned Option Sale | 3,452 | $12.00 | $41,437.80 | (60%) 5.73K to 2.28K | |
| 01-Jul-24 6:00 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 28-Jun-24 | Option Exercise | 3,452 | $6.93 | $23,922.40 | 152% 2.28K to 5.73K | |
| 02-May-24 6:19 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 01-May-24 | Option Exercise | 20,000 | $6.93 | $138,600.00 | 879% 2.28K to 22.28K | |
| 02-May-24 6:19 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 01-May-24 | Planned Option Sale | 20,000 | $14.13 | $282,577.00 | (90%) 22.28K to 2.28K | |
| 03-Apr-24 4:01 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 01-Apr-24 | Option Exercise | 20,000 | $6.93 | $138,600.00 | 879% 2.28K to 22.28K | |
| 03-Apr-24 4:01 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 01-Apr-24 | Planned Option Sale | 20,000 | $16.15 | $323,000.00 | (90%) 22.28K to 2.28K | |
| 19-Mar-24 4:47 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 15-Mar-24 | Option Exercise | 20,000 | $6.93 | $138,600.00 | 879% 2.28K to 22.28K | |
| 19-Mar-24 4:47 PM View: | Usman Nassim Director | Targacept, Inc. (GYRE) | 15-Mar-24 | Planned Option Sale | 20,000 | $17.26 | $345,200.00 | (90%) 22.28K to 2.28K | |
| 22-Nov-23 7:27 PM View: | Gni Group Ltd. 10% Owner | Targacept, Inc. (GYRE) | 30-Oct-23 | Acquisition (other) | 63,588,100 | -- | -- | 15221% 417.8K to 64.01M | |
| 27-Oct-23 7:56 PM View: | Gni Hong Kong Ltd 10% Owner | Targacept, Inc. (GYRE) | 27-Oct-23 | Disposition (other) | 5,371,300 | -- | -- | (100%) 5.37M to 0 | |
| 01-Sep-23 4:07 PM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 25 | -- | -- | (50%) 48 to 24 | |
| 01-Sep-23 4:07 PM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 24 | -- | -- | (100%) 24 to 0 | |
| 01-Sep-23 4:07 PM View: | Miller Seline E. SVP Finance; Interim CFO & PAO | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 6 | -- | -- | (100%) 6 to 0 | |
| 01-Sep-23 4:07 PM View: | Hunt Andrea Director | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 28 | -- | -- | (100%) 28 to 0 | |
| 01-Sep-23 4:07 PM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 25 | -- | -- | (72%) 34 to 9 | |
| 01-Sep-23 4:07 PM View: | Gni Group Ltd. 10% Owner | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 6,267 | -- | -- | (100%) 6.27K to 0 | |
| 01-Sep-23 4:07 PM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 31-Aug-23 | Disposition | 10 | -- | -- | (100%) 9 to 0 | |
| 10-Aug-22 5:19 PM View: | Miller Seline E. SVP Finance; Interim CFO & PAO | Targacept, Inc. (GYRE) | 09-Aug-22 | Private Purchase | 3,250 | $0.47 | $1,527.50 | 100% 3.25K to 6.5K | |
| 10-Aug-22 5:19 PM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 09-Aug-22 | Private Purchase | 3,250 | $0.47 | $1,527.50 | 11% 30.91K to 34.16K | |
| 10-Aug-22 5:17 PM View: | Blouse Grant E. Chief Scientific Officer | Targacept, Inc. (GYRE) | 09-Aug-22 | Private Purchase | 3,250 | $0.47 | $1,527.50 | 53% 6.17K to 9.42K | |
| 16-Feb-22 8:07 PM View: | Blouse Grant E. Chief Scientific Officer | Targacept, Inc. (GYRE) | 09-Feb-22 | Private Purchase | 3,250 | $0.46 | $1,495.00 | 111% 2.92K to 6.17K | |
| 16-Feb-22 8:10 PM View: | Miller Seline E. SVP Finance; Interim CFO & PAO | Targacept, Inc. (GYRE) | 09-Feb-22 | Private Purchase | 3,250 | $0.46 | $1,495.00 | 100% 0 to 3.25K | |
| 16-Feb-22 8:13 PM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 09-Feb-22 | Private Purchase | 3,250 | $0.46 | $1,495.00 | 12% 27.66K to 30.91K | |
| 07-Jan-22 5:33 PM View: | Williams Eddie Director | Targacept, Inc. (GYRE) | 07-Jan-22 | Grant | 12,308 | -- | -- | 55% 22.5K to 34.8K | |
| 07-Jan-22 5:30 PM View: | Hunt Andrea Director | Targacept, Inc. (GYRE) | 07-Jan-22 | Grant | 7,521 | -- | -- | 36% 20.71K to 28.23K | |
| 07-Jan-22 5:31 PM View: | Ling Geoffrey M.D. Director | Targacept, Inc. (GYRE) | 07-Jan-22 | Grant | 12,855 | -- | -- | 68% 18.93K to 31.79K | |
| 05-Oct-21 4:33 PM View: | Ling Geoffrey M.D. Director | Targacept, Inc. (GYRE) | 01-Oct-21 | Grant | 2,858 | -- | -- | 18% 16.08K to 18.93K | |
| 05-Oct-21 4:33 PM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 01-Oct-21 | Grant | 5,839 | -- | -- | 14% 42.95K to 48.79K | |
| 05-Oct-21 4:32 PM View: | Desouza Errol B Director | Targacept, Inc. (GYRE) | 01-Oct-21 | Grant | 3,588 | -- | -- | 14% 26.21K to 29.8K | |
| 05-Oct-21 4:34 PM View: | Williams Eddie Director | Targacept, Inc. (GYRE) | 01-Oct-21 | Grant | 2,980 | -- | -- | 15% 19.52K to 22.5K | |
| 05-Oct-21 4:32 PM View: | Hunt Andrea Director | Targacept, Inc. (GYRE) | 01-Oct-21 | Grant | 1,824 | -- | -- | 10% 18.88K to 20.71K | |
| 11-Aug-21 9:14 AM View: | Levy Howard Chief Medical Officer | Targacept, Inc. (GYRE) | 09-Aug-21 | Private Purchase | 639 | $3.62 | $2,313.18 | 3% 23.39K to 24.03K | |
| 11-Aug-21 9:15 AM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 09-Aug-21 | Private Purchase | 867 | $3.62 | $3,138.54 | 3% 26.8K to 27.66K | |
| 11-Aug-21 9:13 AM View: | Blouse Grant E. Chief Scientific Officer | Targacept, Inc. (GYRE) | 09-Aug-21 | Private Purchase | 1,163 | $3.62 | $4,210.06 | 66% 1.75K to 2.92K | |
| 02-Jul-21 9:51 AM View: | Desouza Errol B Director | Targacept, Inc. (GYRE) | 01-Jul-21 | Grant | 3,406 | -- | -- | 15% 22.81K to 26.21K | |
| 02-Jul-21 9:56 AM View: | Williams Eddie Director | Targacept, Inc. (GYRE) | 01-Jul-21 | Grant | 1,414 | -- | -- | 8% 18.1K to 19.52K | |
| 02-Jul-21 9:53 AM View: | Hunt Andrea Director | Targacept, Inc. (GYRE) | 01-Jul-21 | Grant | 2,886 | -- | -- | 18% 16.0K to 18.88K | |
| 02-Jul-21 9:54 AM View: | Ling Geoffrey M.D. Director | Targacept, Inc. (GYRE) | 01-Jul-21 | Grant | 2,713 | -- | -- | 20% 13.36K to 16.08K | |
| 02-Jul-21 9:54 AM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 01-Jul-21 | Grant | 5,542 | -- | -- | 15% 37.41K to 42.95K | |
| 07-Apr-21 10:55 AM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 05-Apr-21 | Option Exercise | 5,000 | $4.63 | $23,150.00 | 23% 21.8K to 26.8K | |
| 05-Apr-21 1:41 PM View: | Williams Eddie Director | Targacept, Inc. (GYRE) | 01-Apr-21 | Grant | 1,215 | -- | -- | 7% 16.89K to 18.1K | |
| 05-Apr-21 1:37 PM View: | Hunt Andrea Director | Targacept, Inc. (GYRE) | 01-Apr-21 | Grant | 2,480 | -- | -- | 18% 13.52K to 16.0K | |
| 05-Apr-21 1:39 PM View: | Ling Geoffrey M.D. Director | Targacept, Inc. (GYRE) | 01-Apr-21 | Grant | 2,331 | -- | -- | 21% 11.03K to 13.36K | |
| 05-Apr-21 1:38 PM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 01-Apr-21 | Grant | 4,761 | -- | -- | 15% 32.65K to 37.41K | |
| 05-Apr-21 1:37 PM View: | Desouza Errol B Director | Targacept, Inc. (GYRE) | 01-Apr-21 | Grant | 2,926 | -- | -- | 15% 19.88K to 22.81K | |
| 22-Feb-21 9:33 PM View: | Levy Howard Chief Medical Officer | Targacept, Inc. (GYRE) | 09-Feb-21 | Private Purchase | 1,670 | $4.81 | $8,032.70 | 8% 21.72K to 23.39K | |
| 22-Feb-21 9:33 PM View: | Usman Nassim President & CEO Director | Targacept, Inc. (GYRE) | 09-Feb-21 | Private Purchase | 582 | $4.81 | $2,799.42 | 3% 21.22K to 21.8K | |
| 06-Jan-21 4:58 PM View: | Ling Geoffrey M.D. Director | Targacept, Inc. (GYRE) | 05-Jan-21 | Grant | 1,782 | -- | -- | 19% 9.25K to 11.03K | |
| 06-Jan-21 4:57 PM View: | Lawlor Augustine Director | Targacept, Inc. (GYRE) | 05-Jan-21 | Grant | 3,417 | -- | -- | 12% 29.23K to 32.65K | |
| 06-Jan-21 4:47 PM View: | Desouza Errol B Director | Targacept, Inc. (GYRE) | 05-Jan-21 | Grant | 2,129 | -- | -- | 12% 17.75K to 19.88K |
